Application of telenursing as a nursing care delivery model in improving treatment adherence and glycemic control: A scoping review
Background: Diabetes mellitus is one of the chronic diseases that cause the highest mortality and high medical costs;, therefore medication adherence and glycemic control are important in disease management, one of which is through telenursing. Purpose: To determine the telenursing model to imp...
Saved in:
Main Authors: | , , |
---|---|
Format: | Article |
Language: | Indonesian |
Published: |
Universitas Padjadjaran
2023-12-01
|
Series: | JKP (Jurnal Keperawatan Padjajaran) |
Subjects: | |
Online Access: | https://jkp.fkep.unpad.ac.id/index.php/jkp/article/view/2114 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Background: Diabetes mellitus is one of the chronic diseases that cause the highest mortality and high medical costs;, therefore medication adherence and glycemic control are important in disease management, one of which is through telenursing.
Purpose: To determine the telenursing model to improve medication adherence and glycemic control in patients with type 2 diabetes mellitus.
Methods: This study was designed a scoping review. The databases used are CINAHL, PubMed, ScienceDirect and Google Scholar. Articles published from 2016-2022 with appropriate inclusion and exclusion criteria. Thematic analysis was used based on study design, telenursing communication model, telenursing process, duration of telenursing and results.
Results: There were 12 relevant articles out of 2112 articles. We found a telephone call follow up is the most common method used for delivery of telenursing intervention. Telenursing intervention is implemented from at least 3 months until 12 months, and includes the assessment of current disease conditions, assessment of adherence to the prescribed treatment plan, treatment plan information, and solutions or follow-up to current issue.
Conclusion: Telenursing can be used as a nursing care delivery model in the diabetes mellitus type 2 patients because it is proven to reduce glycemic control, improve treatment adherence, reduce body mass index (BMI), glycosylated hemoglobin (HbA1c), and cholesterol, and improve diet adherence, physical exercise and self-management.
|
---|---|
ISSN: | 2338-5324 2442-7276 |